275374-94-2

Usage

Uses

Used in Pharmaceutical Synthesis:
7-Fluoro-6-Methyl Isatin is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be a versatile building block for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
7-Fluoro-6-Methyl Isatin is also utilized in the production of agrochemicals, contributing to the development of new pesticides and other agricultural chemicals that can improve crop yields and protect plants from pests and diseases.
Used in Dye and Pigment Manufacturing:
7-Fluoro-6-Methyl Isatin is used as a raw material in the manufacturing of dyes and pigments. Its chemical properties make it suitable for creating a wide range of colors and shades, which can be used in various industries such as textiles, plastics, and printing.
Used in Organic Chemistry Research:
Due to its unique structure and properties, 7-Fluoro-6-Methyl Isatin is an important compound for research in organic chemistry. It is studied for its potential applications in the development of new synthetic methods, reactions, and compounds with various applications in different fields.
Used in Biological and Pharmacological Studies:
7-Fluoro-6-Methyl Isatin is also being investigated for its potential biological and pharmacological activities. Researchers are exploring its interactions with biological systems and its potential use in the development of new therapeutic agents and treatments for various diseases and conditions.

InChI:InChI=1/C9H6FNO2/c1-4-2-3-5-7(6(4)10)11-9(13)8(5)12/h2-3H,1H3,(H,11,12,13)

Relevant academic research and scientific papers

Use of isatin derivatives as ion channel activating agents

The present invention relates to ion channel activating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as openers of SKCa and IKCa channels. In further aspects, the present invention relates to the use of these SK/IK channel activating agents for the manufacture of medicaments and pharmaceutical compositions comprising the SK/IK channel activating agents. The SK/IK channel activating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK channels, in particular respiratory diseases such as asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, urinary incontinence, bladder outflow obstruction, irritable bowel syndrome, gastrointestinal dysfunction, secretory diarrhea, ischaemia, cerebral ischaemia, ischaemic heart disease, angina pectoris, coronary heart disease, traumatic brain injury, psychosis, anxiety, depression, dementia, memory and attention deficits, Alzheimer's disease, dysmenorrhea, narcolepsy, Reynaud's disease, intermittent claudication, Sjorgren's syndrome, migraine, arrhythmia, hypertension, absence seizures, myotonic muscle dystrophia, xerostomi, diabetes type II, hyperinsulinemia, premature labor, baldness, cancer, and immune suppression.